Current practices of AAHKS members in the treatment of adult osteonecrosis of the femoral head

Journal of Bone and Joint Surgery

Volumn 89, Issue 6, 2007, Pages 1194-1204

  McGrory, Brian J ^a   York, Sally C ^b   Iorio, Richard ^c   Macaulay, William ^d   Pelker, Richard R ^e   Parsley, Brian S ^f   Teeny, Steven M ^b  

^a Orthopaedic Associates of Portland   (United States)

^b Northwest Orthopaedic Institute   (United States)

^c LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTHRODESIS; ARTHROPLASTY; ARTICLE; BONE GRAFT; BONE NECROSIS; DISEASE CLASSIFICATION; FEMUR HEAD; HEALTH SURVEY; HIP SURGERY; HUMAN; KNEE SURGERY; MAJOR CLINICAL STUDY; OSTEOTOMY; PRIORITY JOURNAL; QUESTIONNAIRE; SELF EVALUATION; SYMPTOMATOLOGY; TOTAL HIP PROSTHESIS; UNITED STATES;

EID: 34250210495     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.F.00302     Document Type: Article

References (57)

1. Aldridge JM 3rd, Urbaniak JR. Avascular necrosis of the femoral head: etiology, pathophysiology, classification, and current treatment guidelines. Am J Orthop. 2004;33:327-32.
2. Lieberman JR, Berry DJ, Mont MA, Aaron RK, Callaghan JJ, Rajadhyaksha AD, Urbaniak JR. Osteonecrosis of the hip: management in the 21st century. Instr Course Lect. 2003;52:337-55.
3. Vail TP, Covington DB. The incidence of osteonecrosis. In: Urbaniak JR, Jones JP, editors. Osteonecrosis: etiology, diagnosis, treatment. Rosement, IL: American Academy of Orthopaedic Surgeons; 1997. p 43-9.
4. Cheng EY, Thongtrangan I, Laorr A, Saleh KJ. Spontaneous resolution of osteonecrosis of the femoral head. J Bone Joint Surg Am. 2004;86:2594-9.
5. Hernigou P, Poignard A, Nogler A, Manicom O. Fate of very small asymptomatic stage-I osteonecrotic lesions of the hip. J Bone Joint Surg Am. 2004;86:2589-93.
6. Glueck CJ, Freiberg RA, Sieve L, Wang P. Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clin Orthop Relat Res. 2005;435:164-70.
7. Shuler MS, Rooks MD, Roberson JR. Porous tantalum implant in early osteonecrosis of the hip. J Arthroplasty. 2007;22:26-31.
8. Marciniak D, Furey C, Shaffer JW. Osteonecrosis of the femoral head. A study of 101 hips treated with vascularized fibular grafting. J Bone Joint Surg Am. 2005;87:742-7.
9. Yoon TR, Rowe SM, Chung JY, Song EK, Sun JK, Cheon SY. Gluteus medius muscle pedicle bone grafting for osteonecrosis of the femoral head in young patients. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2005 Feb 23-27; Washington, DC.
10. Xenakis T, Stafilas K, Zacharis KC, Mitsionis G, Kitsoulis P. A new porous tantalum implant for the treatment of femoral head osteonecrosis. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2005 Feb 23-27; Washington, DC.
11. Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res. 2001;386:173-8.
12. Agarwala S, Jain D, Joshi VR, Sule A. Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study. Rheumatology (Oxford). 2005;44:352-9. Erratum in: Rheumatology (Oxford). 2005;44:569.
13. Kim SY, Kim YG, Kim PT, Ihn JC, Cho BC, Koo KH. Vascularized compared with nonvascularized fibular grafts for large osteonecrotic lesions of the femoral head. J Bone Joint Surg Am. 2005;87:2012-8.
14. Rosenwasser MP, Garino JP, Kiernan HA, Michelsen CB. Long term followup of thorough debridement and cancellous bone grafting of the femoral head for avascular necrosis. Clin Orthop Relat Res. 1994;306:17-27.
15. Steinberg ME, Larcom PG, Strafford B, Hosick WB, Corces A, Bands RE, Hartman KE. Core decompression with bone grafting for osteonecrosis of the femoral head. Clin Orthop Relat Res. 2001;386:71-8.
16. Lavernia CJ, Sierra RJ, Grieco FR. Osteonecrosis of the femoral head. J Am Acad Orthop Surg. 1999;7:250-61.
17. Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am. 2006;88:1117-32. Review. Erratum in: J Bone Joint Surg Am. 2006;88:1602. Dosage error in text.
18. Jergesen HE, Khan AS. The natural history of untreated asymptomatic hips in patients who have non-traumatic osteonecrosis. J Bone Joint Surg Am. 1997;79:359-63.
19. Castro FP Jr, Barrack RL. Core decompression and conservative treatment for avascular necrosis of the femoral head: a meta-analysis. Am J Orthop. 2000;29:187-94.
20. Hungerford DS, Jones LC. Asymptomatic osteonecrosis, should it be treated? Clin Orthop Relat Res. 2004;429:124-30.
21. Youm T, Maurer SG, Stuchin SA. Postoperative management after total hip and knee arthroplasty. J Arthroplasty. 2005;20:322-4.
22. Kelsey D, Goodman SB. Design of the femoral component for cementless hip replacement: the surgeon's perspective. Am J Orthop. 1997;26:407-12.
23. Sharkey PF, Sethuraman V, Hozack WJ, Rothman RH, Stiehl JB. Factors influencing choice of implants in total hip arthroplasty and total knee arthroplasty: perspectives of surgeons and patients. J Arthroplasty. 1999;14:281-7.
24. Teeny SM, York SC, Mesko JW, Rea RE. Long-term follow-up care recommendations after total hip and knee arthroplasty: results of the American Association of Hip and Knee Surgeons' member survey. J Arthroplasty. 2003;18:954-62.
25. Dillman DA. Mail and internet surveys: the tailored design method. New York: Wiley; 2000.
26. Field TS, Cadoret CA, Brown ML, Ford M, Greene SM, Hill D, Hornbrook MC, Meenan RT, White MJ, Zapka JM. Surveying physicians: do components of the "Total Design Approach" to optimizing survey response rates apply to physicians? Med Care. 2002;40:596-605.
27. Geography Division, US Department of Commerce, Economics and Statistics Administration, US Census Bureau. Census Bureau regions and division with state FIPScodes. http://www.census.gov/geo/www/us_regdiv.pdf. Accessed 2005 Jun 17.
28. Centers for Medicare and Medicaid Services. Regional office overview. http://www.cms.hhs.gov/about/regions/professionals.asp. Accessed 2005 Jun 17.
29. Steinberg ME, Hayken GD, Steinberg DR. Classification and staging of osteonecrosis. In: Urbaniak JR, Jones JP Jr, editors. Osteonecrosis: etiology, diagnosis, and treatment. Rosemont. IL: American Academy of Orthopaedic Surgeons; 1997. p 277-84.
30. Yoshida T, Kanayama Y, Okamura M, Negoro N, Inoue T, Yoshikawa J. Long-term observation of avascular necrosis of the femoral head in systemic lupus erythematosus: an MRI study. Clin Exp Rheumatol. 2002;20:525-30.
31. Statistical package for the social sciences. Version 12.0. Chicago, IL: SPSS; 2003.
32. Agarwala S, Jain D, Joshi VR, Sule A. Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study. Rheumatology (Oxford). 2005;44:352-9. Erratum in: Rheumatology (Oxford). 2005;44:569.
33. Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am. 2005;87:2155-9.
34. Hernigou P, Habibi A, Bachir D, Galacteros F. The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease. J Bone Joint Surg Am. 2006;88:2565-72.
35. Neumayr LD, Aguilar C, Earles AN, Jergesen HE, Haberkern CM, Kammen BF, Nancarrow PA, Padua E, Milet M, Stulberg BN, Williams RA, Orringer EP, Graber N, Robertson SM, Vichinsky EP; National Osteonecrosis Trial in Sickle Cell Anemia Study Group. Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment. J Bone Joint Surg Am. 2006;88:2573-82.
36. Goker B, Block JA. Risk of contralateral avascular necrosis (AVN) after total hip arthroplasty (THA) for non-traumatic AVN. Rheumatol Int. 2006;26:215-9.
37. Baker SK, Tarnopolsky MA. Statin-associated neuromyotoxicity. Timely Top Med Cardiovasc Dis. 2005;9:E26.
38. Carter G, Goss AN, Doecke C. Bisphosphonates and avascular necrosis of the jaw: a possible association. Med J Aust. 2005;182:413-5.
39. Tiaden JD, Wenzel E, Berthold HK, Muller-Oerlinghausen B. Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system. Semin Thromb Hemost. 2005;31:371-80.
40. Smith SW, Fehring TK, Griffin WL, Beaver WB. Core decompression of the osteonecrotic femoral head. J Bone Joint Surg Am. 1995;77:674-80.
41. Fyda TM, Callaghan JJ, Olejniczak J, Johnston RC. Minimum ten-year follow-up of a cemented total hip replacement in patients with osteonecrosis of the femoral head. Iowa Orthop J. 2002;22:8-19.
42. Dudkiewicz I, Covo A, Salai M, Israeli A, Amit Y, Chechik A. Total hip arthroplasty after avascular necrosis of the femoral head: does etiology affect the results? Arch Orthop Trauma Surg. 2004;124:82-5.
43. Rubinstein RA Jr, Beals RK. The results of treatment of posttraumatic avascular necrosis of the femoral head in young adults: report of 31 patients. Contemp Orthop. 1993;27:527-32.
44. Wroblewski BM, Siney PD. Charnley low-friction arthroplasty in the young patient. Clin Orthop Relat Res. 1992;285:45-7.
45. Wroblewski BM, Siney PD, Fleming PA. Charnley low-frictional torque arthroplasty for avascular necrosis of the femoral head. J Arthroplasty. 2005;20:870-3.
46. D'Antonio JA, Capello WN, Manley MT, Geesink R. Hydroxyapatite femoral stems for total hip arthroplasty: 10- to 13-year followup. Clin Orthop Relat Res. 2001;393:101-11.
47. Capello WN, D'Antonio JA, Feinberg JR, Manley MT. Ten-year results with hydroxyapetite-coated total hip femoral components in patients less than fifty years old. A concise follow-up of a previous report. J Bone Joint Surg Am. 2003;85:885-9.
48. Kim YH, Oh SH, Kim JS, Koo KH. Contemporary total hip arthroplasty with and without cement in patients with osteonecrosis of the femoral head. J Bone Joint Surg Am. 2003;85:675-81.
49. Fye MA, Huo MH, Zatorski LE, Keggi KJ. Total hip arthroplasty performed without cement in patients with femoral head osteonecrosis who are less than 50 years old. J Arthroplasty. 1998;13:876-81.
50. D'Antonio J, Capello W, Manley M, Naughton M, Sutton K. Alumina ceramic bearings for total hip arthroplasty: five-year results of a prospective randomized study. Clin Orthop Relat Res. 2005;436:164-71.
51. Squire M, Fehring TK, Odum S, Griffin WL, Bohannon Mason J. Failure of femoral surface replacement for femoral head avascular necrosis. J Arthroplasty. 2005;20(7 Suppl 3):108-14.
52. Hungerford MW, Mont MA, Scott R, Fiore C, Hungerford DS, Krackow KA. Surface replacement hemiarthroplasty for the treatment of osteonecrosis of the femoral head. J Bone Joint Surg Am. 1998;80:1656-64.
53. Ito H, Matsuno T, Kaneda K. Bipolar hemiarthroplasty for osteonecrosis of the femoral head. A 7- to 18-year followup. Clin Orthop Relat Res. 2000;374:201-11.
54. Chan YS, Shih CH. Bipolar versus total hip arthroplasty for hip osteonecrosis in the same patient. Clin Orthop Relat Res. 2000;379:169-77.
55. Lee SB, Sugano N, Nakata K, Matsui M, Ohzono K. Comparison between bipolar hemiarthroplasty and THA for osteonecrosis of the femoral head. Clin Orthop Relat Res. 2004;424:161-5.
56. Tsumura H, Torisu T, Kaku N, Higashi T. Five-to fifteen-year clinical results and the radiographic evaluation of acetabular changes after bipolar hip arthroplasty for femoral head osteonecrosis. J Arthroplasty. 2005;20:892-7.
57. Schmalzried TP. Total resurfacing for osteonecrosis of the hip. Clin Orthop Relat Res. 2004;429:151-6.